Role of TOPK in lipopolysaccharide-induced breast cancer cell migration and invasion

Inflammation has been known to be linked to invasion or metastasis of breast cancer, which has poor prognosis, although the regulatory mechanism remains to be undiscovered. Here we show that T-LAK cell-originated protein kinase (TOPK) mediates pro-inflammatory endotoxin lipopolysaccharide (LPS)-induced breast cancer cell migration and invasion. The mRNA or protein level of TOPK, toll- like receptor4 (TLR4), interleukin (IL)-6, vascular endothelial growth factor (VEGF) or matrix metalloproteinase9 (MMP9) genes related to TLR4 signaling or tumor progression was induced by LPS treatment in MCF7 breast cancer cells, but the induction was abolished by stable knocking down of TOPK in MCF7 cells. Also, TOPK depletion decreased LPS-induced phosphorylation of p38, but not ERK and JNK among mitogen-activated protein kinases (MAPKs). On the other hand, we revealed that TOPK is essential for transcriptional activity of NF-κB or MMP9 promoter triggered by LPS. The induced promoter activity of NF-κB or MMP9 but not AP-1 was inhibited by knocking down of TOPK. Furthermore, we demonstrated that inhibitor of TOPK or MMP9 as well as MMP9 siRNA efficiently blocked LPS-induced migration or invasion of breast cancer cell lines. Interestingly, both of expression of TOPK and TLR4 were markedly increased in high-grade breast cancer. Collectively, we conclude that TOPK functions as a key mediator of LPS/TLR4-induced breast cancer cell migration and invasion through regulation of MMP9 expression or activity, implying a potential role of TOPK as a therapeutic target linking LPS-induced inflammation to breast cancer development.

[1]  M. Karin,et al.  Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment , 2016, Cell.

[2]  Mu-Kuan Chen,et al.  PBK/TOPK Expression Predicts Prognosis in Oral Cancer , 2016, International journal of molecular sciences.

[3]  Jianhua Xu,et al.  TLR4 siRNA inhibits proliferation and invasion in colorectal cancer cells by downregulating ACAT1 expression. , 2016, Life sciences.

[4]  Heshui Wu,et al.  Soluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway , 2016, Scientific Reports.

[5]  Yusuke Nakamura,et al.  T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer. , 2016, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  N. Suh,et al.  Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer , 2016, Oncotarget.

[7]  M. Karin,et al.  Immunity, inflammation, and cancer: an eternal fight between good and evil. , 2015, The Journal of clinical investigation.

[8]  F. Ren,et al.  Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis , 2015, PloS one.

[9]  S. Raghav,et al.  TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells , 2015, The Prostate.

[10]  Hong Shen,et al.  PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma. , 2015, Human pathology.

[11]  Yugang Wang,et al.  Salinomycin inhibits hepatocellular carcinoma cell invasion and migration through JNK/JunD pathway-mediated MMP9 expression , 2014, Oncology reports.

[12]  Chunyan He,et al.  Toll-Like Receptor 4 Prompts Human Breast Cancer Cells Invasiveness via Lipopolysaccharide Stimulation and Is Overexpressed in Patients with Lymph Node Metastasis , 2014, PloS one.

[13]  Yu-jin Jeong,et al.  Activation of TOPK by lipopolysaccharide promotes induction of inducible nitric oxide synthase through NF-κB activity in leukemia cells. , 2014, Cellular signalling.

[14]  A. Farina,et al.  Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression , 2014, Cancers.

[15]  R. Benya,et al.  DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer. , 2013, Cancer research.

[16]  H. Redmond,et al.  Silencing of TLR4 Increases Tumor Progression and Lung Metastasis in a Murine Model of Breast Cancer , 2013, Annals of Surgical Oncology.

[17]  Lu Gao,et al.  Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide , 2012, BMC Medicine.

[18]  Preclinical S Tudy Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes avb3-mediated adhesion and invasive migration , 2012 .

[19]  Yusuke Nakamura,et al.  Critical roles of LGN/GPSM2 phosphorylation by PBK/TOPK in cell division of breast cancer cells , 2010, Genes, chromosomes & cancer.

[20]  Z. Dong,et al.  Requirement of T-lymphokine-activated killer cell-originated protein kinase for TRAIL resistance of human HeLa cervical cancer cells. , 2010, Biochemical and biophysical research communications.

[21]  Gang Li,et al.  Lipopolysaccharide promotes adhesion and invasion of hepatoma cell lines HepG2 and HepG2.2.15 , 2010, Molecular Biology Reports.

[22]  T. Whiteside,et al.  TLR4 signaling induced by lipopolysacharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer , 2009, Oncogene.

[23]  Feng Zhu,et al.  T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation. , 2007, Cancer research.

[24]  Yusuke Nakamura,et al.  PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer. , 2006, Cancer research.

[25]  J. Wang,et al.  Parallel session BOncology III - Tumor invasion, metastasis, proteases, and extracellular matrix 2Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-κB dependent activation of the urokinase plasminogen activator system , 2006 .

[26]  J. Platt,et al.  Conditional signaling by Toll‐like receptor 4 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Y. Abe,et al.  Cloning and Expression of a Novel MAPKK-like Protein Kinase, Lymphokine-activated Killer T-cell-originated Protein Kinase, Specifically Expressed in the Testis and Activated Lymphoid Cells* , 2000, The Journal of Biological Chemistry.

[28]  Y. Oshika,et al.  P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. , 1996, British Journal of Cancer.